Dried plum polyphenols attenuate the detrimental effects of TNF-α on osteoblast function coincident with up-regulation of Runx2, Osterix and IGF-I

Journal of Nutritional Biochemistry

Volumn 20, Issue 1, 2009, Pages 35-44

  Bu, So Young ^a   Hunt, Tamara S ^b   Smith, Brenda J ^a,b  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Antioxidants; Bone; Osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; POLYPHENOL; PROTEIN LYSINE 6 OXIDASE; SOMATOMEDIN C; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; MOUSE; NONHUMAN; OSTEOBLAST; PROTEIN EXPRESSION; UPREGULATION;

3T3 CELLS; ANIMALS; CORE BINDING FACTOR ALPHA 1 SUBUNIT; FLAVONOIDS; GENE EXPRESSION REGULATION; INSULIN-LIKE GROWTH FACTOR I; MICE; OSTEOBLASTS; PHENOLS; PLANT EXTRACTS; PROTEIN-LYSINE 6-OXIDASE; PRUNUS; RANK LIGAND; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

PRUNUS DOMESTICA;

EID: 57049151379     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2007.11.012     Document Type: Article

References (49)

1. Rodan G.A., and Martin T.J. Therapeutic approaches to bone diseases. Science 289 (2000) 1508-1514
2. Manolagas S.C. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21 2 (2000) 115-137
3. Roodman G.D. Cell biology of the osteoclast. Exp Hematol 27 (1999) 1229-1241
4. Rodan G.A. Introduction to Bone Biology. Bone 13 (1992) S3-S6
5. Jones D.H., Kong Y.Y., and Penninger J.M. Role of RANKL and RANK in bone loss and arthritis. Ann Rheum Dis 61 (2002) 32-39
6. Wei S., Kitaura H., Zhou P., Ross F.P., and Teitelbaum S.L. IL-1 mediates TNF-induced osteoclastogenesis. J Clin Invest 115 (2005) 282-290
7. Zou W., and Bar-Shavit Z. Dual modulation of osteoclast differentiation by lipopolysaccharide. J Bone Miner Res 17 (2002) 1211-1218
8. Cenci S., Weitzmann M.N., Roggia C., Namba N., Novack D., Woodring J., et al. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest 106 (2000) 1229-1237
9. Scharla S.H., Strong D.D., Mohan S., Chevalley T., and Linkhart T.A. Effect of tumor-necrosis-factor-alpha on the expression of insulin-like growth-factor-I and insulin-like growth-factor binding-protein-4 in mouse osteoblasts. Eur J Endocrinol 131 (1994) 293-301
10. Gilbert L., He X.F., Farmer P., Boden S., Kozlowski M., Rubin J., et al. Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology 141 (2000) 3956-3964
11. Pischon N., Darbois L.M., Palamakumbura A.H., Kessler E., and Trackman P.C. Regulation of collagen deposition and lysyl oxidase by tumor necrosis factor-alpha in osteoblasts. J Biol Chem 279 (2004) 30060-30065
12. Lu X.H., Gilbert L., He X.F., Rubin J., and Nanes M.S. Transcriptional regulation of the osterix (Osx, Sp7) promoter by tumor necrosis factor identifies disparate effects of mitogen-activated protein kinase and NF kappa B pathways. J Biol Chem 281 (2006) 6297-6306
13. Gilbert L., He X.F., Farmer P., Rubin J., Drissi H., van Wijnen A.J., et al. Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2 alpha A) is inhibited by tumor necrosis factor-alpha. J Biol Chem 277 (2002) 2695-2701
14. Pacifici R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11 (1996) 1043-1051
15. Lean J.M., Davies J.T., Fuller K., Jagger C.J., Kirstein B., Partington G.A., et al. A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest 112 (2003) 915-923
16. Muhlbauer R.C., Lozano A., Reinli A., and Wetli H. Various selected vegetables, fruits, mushrooms and red wine residue inhibit bone resorption in rats. J Nutr 133 (2003) 3592-3597
17. Woo J.T., Nakagawa H., Notoya M., Yonezawa T., Udagawa N., Lee I.S., et al. Quercetin suppresses bone resorption by inhibiting the differentiation and activation of osteoclasts. Biol Pharm Bull 27 (2004) 504-509
18. Horcajada-Molteni M.N., Crespy V., Coxam V., Davicco M.J., Remesy C., and Barlet J.P. Rutin inhibits ovariectomy-induced osteopenia in rats. J Bone Miner Res 15 (2000) 2251-2258
19. Mizutani K., Ikeda K., Kawai Y., and Yamori Y. Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells. Biochem Biophys Res Commun 253 (1998) 859-863
20. Bai X.C., Lu D., Bai J., Zheng H., Ke Z.Y., Li X.M., et al. Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappa B. Biochem Biophys Res Commun 314 (2004) 197-207
21. Stacewicz-Sapuntzakis M., Bowen P.E., Hussain E.A., Damayanti-Wood B.I., and Farnsworth N.R. Chemical composition and potential health effects of prunes: a functional food?. Crit Rev Food Sci Nutr 41 (2001) 251-286
22. Franklin M., Bu S., Lerner M., Lancaster E., Bellmer D., Marlow D., et al. Dried plum prevents bone loss in a male osteoporosis model via IGF-I and the RANK pathway. Bone 39 (2006) 1331-1342
23. Arjmandi B.H., Khalil D.A., Lucas E.A., Georgis A., Stoecker B.J., Hardin C., et al. Dried plums improve indices of bone formation in postmenopausal women. J Women's Health Gend Med 11 (2002) 61-68
24. Arjmandi B.H., Lucas E.A., Juma S., Soliman A., Stoecker B.J., Khalil D.A., et al. Prune prevents ovariectomy-induced bone loss in rats. JANA 4 (2001) 50-56
25. Deyhim F., Stoecker B.J., Brusewitz G.H., Devareddy L., and Arjmandi B.H. Dried plum reverses bone loss in an osteopenic rat model of osteoporosis. Menopause 12 (2005) 755-762
26. Bu S.Y., Lucas E.A., Franklin M., Marlow D., Brackett D.J., Boldrin E.A., et al. Comparison of dried plum supplementation and intermittent PTH in restoring bone in osteopenic orchidectomized rats. Osteoporos Int 18 (2007) 931-942
27. Picherit C., Bennetau-Pelissero C., Chanteranne B., Lebecque P., Davicco M.J., Barlet J.P., et al. Soybean isoflavones dose-dependently reduce bone turnover but do not reverse established osteopenia in adult ovariectomized rats. J Nutr 131 (2001) 723-728
28. Kim D.O., Chun O.K., Kim Y.J., Moon H.Y., and Lee C.Y. Quantification of polyphenolics and their antioxidant capacity in fresh plums. J Agric Food Chem 51 (2003) 6509-6515
29. Singleton V.L., Orthofer R., and Lamuela-Raventos R.M. Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin-Ciocalteu reagent. Oxid Antioxid 299 (1999) 152-178
30. Al-Nasiry S., Geusens N., Hanssens M., Luyten C., and Pijnenborg R. The use of Alamar Blue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells. Hum Reprod 22 (2007) 1304-1309
31. Stoscheck C.M. Quantitation of protein. Methods Enzymol 182 (1990) 50-68
32. Stanford C.M., Jacobson P.A., Eanes E.D., Lembke L.A., and Midura R.J. Rapidly forming apatitic mineral in an osteoblastic cell-line (Umr-106-01 Bsp). J Biol Chem 270 (1995) 9420-9428
33. Schett G., Redlich K., Hayer S., Zwerina J., Bolon B., Dunstan C., et al. Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice. Arthritis Rheum 48 (2003) 2042-2051
34. Eliseev R.A., Schwarz E.M., Zuscik M.J., O'Keefe R.J., Drissi H., and Rosier R.N. Smad7 mediates inhibition of Saos2 osteosarcoma cell differentiation by NF kappa B. Exp Cell Res 312 (2006) 40-50
35. Li Y., Li A., Strait K., Zhang H., Nanes M.S., and Weitzmann M.N. Endogenous TNF alpha loweres maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kB. J Bone Miner Res 22 (2007) 646-655
36. Kim Y.J., Lee M.H., Wozney J.M., Cho J.Y., and Ryoo H.M. Bone morphogenetic protein-2-induced alkaline phosphatase expression is stimulated by Dlx5 and repressed by Msx2. J Biol Chem 279 (2004) 50773-50780
37. Wang B.L., Dai C.L., Quan J.X., Zhu Z.F., Zheng F., Zhang H.X., et al. Parathyroid hormone regulates osterix and Runx2 mRNA expression predominantly through protein kinase A signaling in osteoblast-like cells. J Endocrinol Invest 29 (2006) 101-108
38. Nakajima A., Shimoji N., Shiomi K., Shimizu S., Moriya H., Einhorn T.A., et al. Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34). J Bone Miner Res 17 (2002) 2038-2047
39. Pan W., Quarles L.D., Song L.H., Yu Y.H., Jiao C., Tang H.B., et al. Genistein stimulates the osteoblastic differentiation via NO/cGMP in bone marrow culture. J Cell Biochem 94 (2005) 307-316
40. Zapf J., and Froesch E.R. Insulin-like growth-factors somatomedins - structure, secretion, biological actions and physiological-role. Horm Res 24 (1986) 121-130
41. Li Y.M., Schacher D.H., Liu Q., Arkins S., Rebeiz N., McCusker Jr. R.H., et al. Regulation of myeloid growth and differentiation by the insulin-like growth factor I receptor. Endocrinology 138 (1997) 362-368
42. Patel M.B., Arden N.K., Masterson L.M., Phillips D.I., Swaminathan R., Syddall H.E., et al. Investigating the role of the growth hormone-insulin-like growth factor (GH-IGF) axis as a determinant of male bone mineral density (BMD). Bone 37 (2005) 833-841
43. Saito M., Fujii K., Soshi S., and Tanaka T. Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation-induced pentosidine in the femoral neck cortex in cases of femoral neck fracture. Osteoporos Int 17 (2006) 986-995
44. Ammann P., and Rizzoli R. Bone strength and its determinants. Osteoporos Int 14 (2003) S13-S18
45. Hofbauer L.C., Khosla S., Dunstan C.R., Lacey D.L., Boyle W.J., and Riggs B.L. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15 (2000) 2-12
46. Hofbauer L.C., Lacey D.L., Dunstan C.R., Spelsberg T.C., Riggs B.L., and Khosla S. Interleukin-1 beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 25 (1999) 255-259
47. Landis W.J. Mineral characterization in calcifying tissues: atomic, molecular and macromolecular perspectives. Conn Tissue Res 35 (1996) 1-8
48. Frossard E., Bucher M., Machler F., Mozafar A., and Hurrell R. Potential for increasing the content and bioavailability of Fe, Zn and Ca in plants for human nutrition. J Sci Food Agric 80 (2000) 861-879
49. Cremin P., Kasim-Karakas S., and Waterhouse A.L. LC/ES-MS detection of hydroxycinnamates in human plasma and urine. J Agric Food Chem 49 4 (2001) 1747-1750